How Orthopedic and Cardiology Implantable Device Manufacturers Can See Double Digit Growth Using Bang Surgical
Summary
In addition to lower sales costs and improved margins, implant manufacturers will be poised for growth in a previously untouched market share of surgeon conversion.To ensure that hospitals and surgeons work collaboratively on “Value Analysis or Justification Committees” to drive down costs yet maintain outcomes, the Affordable Care Act (ACA) provides financial incentives to surgeons in two ways: higher payor reimbursements and ACOs.Payor Reimbursements – Under the ACA, Medicare is ranking hospitals/surgeons nationally in terms of patient outcomes and the cost(s) of the procedure.But with remote based support, surgeons can re-train without travel logistics making the prospect of conversion much more viable.In summary, higher profit margins & double digit growth is obtainable without the high costs of M&As.In addition to lower sales costs and improved margins, implant manufacturers will be poised for growth in a previously untouched market share of surgeon conversion.Double digit growth is an easy and attainable short term reality.Contactinfo@bangsurgical.comBang Surgical1235 Puerta Del Sol #100San Clemente, CA 92673(949) 385-2220 Contact Information Bang Surgical Ted Schwartz 949-292-9001 www.bangsurgical.com Click here to view the list of recent Press Releases from Bang Surgical Promote Your Business Press Release Pricing Email this page to a friend